Macrovascular and microvascular outcomes of metabolic surgery versus GLP-1 receptor agonists in patients with diabetes and obesity
Hamlet Gasoyan, Mohammad Hesam Alavi, Alexander Zajichek, Nicholas J. Casacchia, Abdullah Al-Jabri, James Bena, Xiaoxi Feng, Rickesha Wilson, Ricard Corcelles, W. Scott Butsch, Rishi P. Singh, Nikhil Das, Hejin Jeong, Amgad Mentias, W.H. Wilson Tang, Bartolomé Burguera, Raul J. Rosenthal, Steven E. Nissen, Michael B. Rothberg, Ali Aminian
Topics & Concepts
MedicineMaceHazard ratioInternal medicineNephropathyDiabetes mellitusObesityRetinopathyMetabolic syndromeIncidence (geometry)Confidence intervalType 2 diabetesCumulative incidenceAdverse effectSurgeryProportional hazards modelDiabetic nephropathyBody mass indexDiabetic retinopathyType 2 Diabetes MellitusMetabolic control analysisCardiologyRisk factorRandomized controlled trialEndocrinologyMetabolic equivalentBariatric Surgery and OutcomesDiabetes Treatment and ManagementDiet and metabolism studies